Self-Assembling Peptides with Insulin-Like Growth Factor Mimicry

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Molecular Signaling

Background:

• Growth factor (GF) mimicry aims to replicate the functions of natural signaling molecules.
• Current GF mimicry faces challenges in targeted delivery and receptor binding stability.
• Self-assembling peptides (SAPs) offer a potential platform to overcome these limitations.

Purpose of the Study:

• To develop synthetic, self-assembling growth factors (GFs) that mimic insulin-like growth factor (IGF) signaling.
• To create biocompatible peptide hydrogels for enhanced GF mimicry applications.
• To address challenges in targeted delivery and long-term stability of GF mimics.

Main Methods:

• Utilized a self-assembling peptide (SAP) platform to create synthetic IGF-signaling GFs.
• Fabricated peptide hydrogels with demonstrated biocompatibility.
• Assessed hydrogel binding to IGF receptors, proangiogenic signaling activation, and in vitro angiogenesis.

Main Results:

• Peptide hydrogels exhibited dose-dependent binding to target IGF receptors.
• Activated proangiogenic signaling pathways and facilitated the formation of angiogenic microtubules in vitro.
• Demonstrated long-term stability of infiltrated hydrogels, lasting weeks to months.

Conclusions:

• Developed stable, self-assembling peptide hydrogels mimicking IGF signaling.
• Enhanced targeting and prolonged stability of SAP/GF mimicry implants shown.
• Potential for improved efficacy and safety in future GF mimic therapeutics.